Veenu Aulakh
Director @ Acumen
San Francisco, United States
Veenu Aulakh is a seed investor at Acumen in San Francisco focused on Health Care and Medical. Veenu Aulakh is the former Executive Director at the Center for Care Innovations. Currently, she serves as the Director of Acumen. Veenu attended the University of Michigan.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Veenu Aulakh invests in
Stages Veenu Aulakh invests in
Countries Veenu Aulakh invests in
Investment Focus
Industry
- Health Care 2 (100%)
- Medical 1 (50%)
- Women's 1 (50%)
- Hospital 1 (50%)
- Software 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Malama Health offers holistic support through community-based doulas, covering various services like pregnancy care and postpartum recovery. The company connects community-based doulas, health plans, and clinical systems across Medicaid markets through a unified operating model that standardizes referral processes, data tracking, risk management,and quality assessment. By incorporating remote patient monitoring, chronic disease management, and Doula-Care Navigators, Malama Health assists women from pregnancy through the postpartum period, addressing clinical requirements, social health factors, and long-term disease prevention all in one location. | $6.9M / Seed / Mar 12, 2026 | |
|
|
Pear Suite is a digital health company that helps community health workers to address social determinants of health through culturally sensitive care navigation.. The cloud-based platform of Pear Suite enables anyone to better assess and address social determinants of health in a scalable, cost-effective, and person-centered manner. Its platform,unlike other assessment tools, enables anyone to assess and address an individual's social drivers of health through smart scripts, logic modeling, and actionable dashboards. | $7.6M / Series A / Oct 14, 2025 |
Co-Investors
About Acumen
Acumen is a nonprofit venture fund that invests in early-stage companies bringing critical services like agriculture, clean energy, education, financial inclusion, healthcare and workforce development to low-income communities in 14 countries across East and West Africa, South Asia, Latin America, and the United States. Since 2001, Acumeninvested $128 million in 128 companies that have transformed the lives of over 308 million low-income people.
Acumen Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Adekemi Ajayi
Regional Director, West Africa
|
|||
|
Carsten Stendevad
President and CIO
|
|||
|
Veenu Aulakh
Director
|
|||
|
Ajit Mahadevan
Country Director
|
|||
|
Amon Anderson
Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Veenu Aulakh invest in?
Veenu Aulakh invests primarily in Health Care, Medical and Women's startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Veenu Aulakh last invest?
The most recent investment recorded for Veenu Aulakh closed in Mar 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!